GLP 1 medications have changed the conversation around obesity, metabolic health, inflammation, and chronic disease. For many patients, they have opened doors that previously felt out of reach. Yet as these medications become more widely available, a new challenge has emerged: access does not always equal quality care.

Too often, patients are handed a prescription with little guidance on what comes next. Questions about dosing, side effects, medication selection, long term maintenance, nutrition, and lifestyle changes are left unanswered. What works for one patient may not work for another, and a one size fits all approach rarely delivers the best outcomes.

That is the problem Mochi Health set out to solve.

As a Presenting Sponsor of the Lipedema Summit, Mochi Health has built its model around personalized, physician guided care that extends far beyond simply prescribing medication. Their focus is on helping patients build a long term relationship with a provider who can adjust treatment plans, answer questions, monitor progress, and adapt care as needs evolve over time. 
‍

Why Personalization Matters

One of the biggest misconceptions about GLP 1 medications is that there is a single path that works for everyone.

According to Dr. Myra Ahmad, CEO of Mochi Health, patients come to treatment with very different goals, medical histories, and health conditions. Some are focused on weight loss. Others are managing PCOS, metabolic dysfunction, insulin resistance, inflammation, or multiple overlapping conditions. Some prefer injectable medications, while others are interested in oral options. Some respond well to their first medication, while others require adjustments along the way.  

Rather than forcing patients into a standardized protocol, Mochi Health allows providers to tailor treatment plans to the individual, helping patients determine which medication, dosage, and long term strategy may be the best fit for their needs.  

Beyond the Prescription

Mochi Health was designed to mirror what many patients hope to find in traditional primary care: an ongoing relationship with a trusted provider.

Patients select a provider and continue working with that same clinician over time. The platform includes unlimited visits and unlimited messaging, allowing patients to ask questions, discuss side effects, adjust treatment plans, and receive guidance as their needs change.  

That level of access can be especially important for patients using GLP 1 medications, where dosing often requires ongoing adjustments.

As Dr. Ahmad explains, some patients do well on very low doses while others require gradual increases over time. The goal is not simply to move everyone to the highest dose possible. Instead, providers work with patients to find the lowest effective dose that delivers results while minimizing side effects. Her advice is simple: low and slow is often the best path forward.  

The Growing Role of GLP 1 Medications

While GLP 1 medications are most commonly associated with weight loss, researchers continue to uncover new areas where they may provide benefits.

During her Summit interview, Dr. Ahmad discussed growing interest in the role GLP 1 medications may play in inflammation, autoimmune conditions, metabolic disorders, addiction pathways, and even neurodegenerative diseases. Research is ongoing, but the potential applications continue to expand as scientists learn more about how these medications affect multiple systems throughout the body.  

For many women living with Lipedema, this area of research is particularly interesting given the inflammatory nature of the disease and the growing number of patients reporting improvements in symptoms beyond weight loss alone.  

Why Provider Guidance Matters

As access to GLP 1 medications expands, patients are being presented with more choices than ever before.

New medications continue to enter the market. Oral formulations are becoming available. Different dosing strategies are emerging. Compounding options, insurance coverage questions, and online providers have added additional complexity to an already crowded landscape.  

Dr. Ahmad believes one thing remains essential regardless of which medication a patient ultimately chooses: provider oversight.

She cautions against self managing treatment or obtaining medications through unregulated sources. Patients should work with providers they trust, understand their options, have access to ongoing support, and feel comfortable discussing challenges as they arise.  

According to Mochi Health, successful outcomes are not just about medication. They also involve nutrition, exercise, behavioral changes, realistic expectations, and a strong support system. Every Mochi patient receives access to a registered dietitian, helping reinforce healthy habits alongside medical treatment.  

Looking Beyond the Scale

One of the most meaningful parts of Dr. Ahmad’s conversation centered around what success actually looks like.

While many patients celebrate weight loss milestones, some of the most memorable stories involve something far simpler: walking comfortably with grandchildren, fitting into an airplane seat without worry, visiting a theme park, or participating in activities that once felt impossible.  

Those moments serve as an important reminder that health is about far more than a number on a scale.

For many patients, the goal is not simply losing weight. It is gaining freedom, mobility, confidence, and the ability to fully participate in everyday life.

Visit Mochi Health at the Lipedema Summit

As Presenting Sponsor of the Lipedema Summit, Mochi Health is helping bring important conversations about metabolic health, obesity medicine, inflammation, and GLP 1 therapies to patients around the world.

Visit Mochi Health’s virtual booth to learn more about their personalized care model, physician guided treatment programs, nutrition resources, and ongoing patient support.

Booth:
https://event.lipedemasummit.com/sponsors/mochi-health/

Website:
https://joinmochi.com/lp/marketplace?utm_source=lipedema&utm_medium=referral&utm_campaign=lipedema_summit

Learn more from Dr. Myra Ahmad’s Summit session and discover how personalized, long term care may help patients navigate the rapidly evolving world of GLP 1 treatment.